More than one small-cap pharma share saw a breakthrough in the past week, with some key approvals and news of commercial tie-ups lifting valuations.Read More

You might also be interested in reading Wall Street must speak up as Trump continues his attacks on Federal Reserve boss, says ALEX BRUMMER.